Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharvaris N.V. (PHVS)

Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharvaris N.V. EMMY NOETHERWEG 2 LEIDEN P7 2333 NLD

www.pharvaris.com Employees: 129 P: 31-71-203-6410

Sector:

Medical

Description:

Pharvaris N.V. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema and other bradykinin-B2-receptor-mediated indications. Pharvaris N.V. is based in ZUG, Switzerland.

Key Statistics

Overview:

Market Capitalization, $K 1,869,360
Enterprise Value, $K 1,539,350
Shares Outstanding, K 65,408
Float, K 57,664
% Float 88.16%
Short Interest, K 712
Short Float 1.09%
Days to Cover 3.73
Short Volume Ratio 0.56
% of Insider Shareholders 11.84%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -198,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -54,930 K
EBIT, $ -192,130 K
EBITDA, $ -191,660 K

Growth:

1-Year Return 106.93%
3-Year Return 209.84%
5-Year Return 20.21%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 45.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.84 on 04/02/26
Next Earnings Date 05/12/26 [--]
Earnings Per Share ttm -3.37
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year -23.53%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PHVS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.96%
Return-on-Assets % -64.18%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.11
Book Value/Share 4.71
Interest Coverage -2.83
60-Month Beta -2.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.